Table 7.
Associations between GOLD classifications and prospective total moderate-to-severe annual exacerbation rate
GOLD classification | Univariate analysis
|
Multivariate analysisa
|
||
---|---|---|---|---|
IRR (95% CI) | P-value | IRR (95% CI) | P-value | |
| ||||
GOLD 2007 | ||||
Stage I | Reference | Reference | ||
Stage II | 2.3 (1.3–4.1) | 0.0069 | 2.0 (1.0–3.8) | 0.036 |
Stage III | 2.9 (1.6–5.4) | <0.001 | 2.3 (1.2–4.6) | 0.014 |
Stage IV | 3.8 (1.8–7.9) | <0.001 | 3.2 (1.4–7.3) | 0.006 |
GOLD 2013 | ||||
Group (A) | Reference | Reference | ||
Group (B) | 2.8 (1.7–4.4) | <0.001 | 3.1 (1.8–5.2) | <0.001 |
Group (C) | 2.3 (1.3–4.3) | 0.008 | 2.0 (1.0–4.2) | 0.052 |
Group (D) | 4.6 (2.9–7.2) | <0.001 | 5.1 (3.0–8.4) | <0.001 |
GOLD 2017 | ||||
Group (A) | Reference | Reference | ||
Group (B) | 2.5 (1.6–3.4) | <0.001 | 2.4 (1.6–3.5) | <0.001 |
Group (C) | 2.3 (1.0–5.3) | 0.060 | 1.0 (0.3–3.6) | 0.997 |
Group (D) | 5.1 (3.3–7.9) | <0.001 | 5.3 (3.3–8.6) | <0.001 |
Reclassified GOLD 2017 with combined group | ||||
Group (A) | Reference | Reference | ||
Group (B) | 2.3 (1.6–3.4) | <0.001 | 2.5 (1.6–3.7) | <0.001 |
Group (C+D) | 4.7 (3.1–7.2) | <0.001 | 4.8 (3.0–7.7) | <0.001 |
Note:
Adjusted for age, sex, body mass index, and pack-years.
Abbreviation: IRR, incidence rate ratio.